Barbara Mittleman currently serves as the Chief Strategy Officer and Vice Chairman at WayMark Systems, where she leverages her extensive experience in drug and diagnostic development to drive innovative collaborations across the life sciences sector. With a robust background in immunology and clinical research, Barbara...
Barbara Mittleman currently serves as the Chief Strategy Officer and Vice Chairman at WayMark Systems, where she leverages her extensive experience in drug and diagnostic development to drive innovative collaborations across the life sciences sector. With a robust background in immunology and clinical research, Barbara is instrumental in spearheading key projects that focus on mapping the complex ecosystem of biomedical research and healthcare. Her leadership at WayMark involves orchestrating multi-stakeholder arrangements that integrate insights from academia, industry, and policy-making to enhance the understanding of biomarkers and their applications in rheumatology and other fields.
At WayMark Systems, Barbara is at the forefront of developing novel visualizations that elucidate the intricate relationships among ecosystem participants, thereby revealing the underlying drivers and requirements for successful drug development and medical research. Her expertise in biostatistics and pharmacology allows her to analyze data effectively, ensuring that the collaborative efforts yield actionable insights that can influence public health policies and improve patient outcomes.
Barbara’s previous role as VP of Clinical and Head of Immunology at Nodality Inc. further solidified her reputation as a leader in the field, where she championed the use of multi-parameter flow cytometry to advance diagnostic capabilities. Her commitment to fostering cross-sectoral collaborations not only enhances scientific discovery but also paves the way for innovative therapeutic solutions. As she continues to navigate the evolving landscape of life sciences, Barbara Mittleman remains dedicated to bridging gaps between research, policy, and practice, ultimately striving to improve healthcare delivery and patient care.
